1. Ouyang Y, Yin J, Wang W, Shi H, Shi Y, Xu B, Qiao L, Feng Y, Pang L, Wei F, Guo X, Jin R, Chen D. Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19. Clin Infect Dis. 2020 Nov 19;71(16):2052-2060. doi: 10.1093/cid/ciaa462. PMID: 32307550; PMCID: PMC7188184.

2. Ouyang Y, Liu X, Li H, Cui S, Yan H, Pan X. RNA Sequencing Analyses Reveal the Potential Mechanism of Pulmonary Injury Induced by Gallium Arsenide Particles in Human Bronchial Epithelioid Cells. Sci Rep. 2020 May 26;10(1):8685. doi: 10.1038/s41598-020-65518-8. PMID: 32457348; PMCID: PMC7250905.

3. Li X, Li C, Zhang L, Wu M, Cao K, Jiang F, Chen D, Li N, Li W. The significance of exosomes in the development and treatment of hepatocellular carcinoma. Mol Cancer. 2020 Jan 4;19(1):1. doi: 10.1186/s12943-019-1085-0. PMID: 31901224; PMCID: PMC6942270.

4. Li X, Li H, Li C, Xia W, Li A, Li W. Traditional Chinese Medicine Can Improve the Immune Reconstruction of HIV/AIDS Patients. AIDS Res Hum Retroviruses. 2020 Apr;36(4):258-259. doi: 10.1089/AID.2019.0274. PMID: 31958968.

5. Gao YX, Yang TW, Yin JM, Yang PX, Kou BX, Chai MY, Liu XN, Chen DX. Progress and prospects of biomarkers in primary liver cancer (Review). Int J Oncol. 2020 Jul;57(1):54-66. doi: 10.3892/ijo.2020.5035. Epub 2020 Apr 1. PMID: 32236573.

6. Wang W, Su B, Pang L, Qiao L, Feng Y, Ouyang Y, Guo X, Shi H, Wei F, Su X, Yin J, Jin R, Chen D. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients. Cell Mol Immunol. 2020 Jun;17(6):650-652. doi: 10.1038/s41423-020-0447-2. Epub 2020 Apr 28. PMID: 32346099; PMCID: PMC7186533.

7. Shi H, Wang W, Yin J, Ouyang Y, Pang L, Feng Y, Qiao L, Guo X, Shi H, Jin R, Chen D. The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia. Cell Death Dis. 2020 Jun 8;11(6):429. doi: 10.1038/s41419-020-2636-4. PMID: 32513989; PMCID: PMC7276960.

8. Wei LL, Wang WJ, Chen DX, Xu B. Dysregulation of the immune response affects the outcome of critical COVID-19 patients. J Med Virol. 2020 Nov;92(11):2768-2776. doi: 10.1002/jmv.26181. Epub 2020 Jul 11. PMID: 32543740; PMCID: PMC7323247.

9. Zhang Y, Gao Y, Qiao L, Wang W, Chen D. Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19). Ann Intern Med. 2020 Sep 1;173(5):402-404. doi: 10.7326/L20-0227. Epub 2020 Apr 13. PMID: 32282871; PMCID: PMC7175423.

10. Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C, Chai X, He R, Li X, Lv Q, Zhu H, Deng W, Xu Y, Wang Y, Qiao L, Tan Y, Song L, Wang G, Du X, Gao N, Liu J, Xiao J, Su XD, Du Z, Feng Y, Qin C, Qin C, Jin R, Xie XS. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells. Cell. 2020 Jul 9;182(1):73-84.e16. doi: 10.1016/j.cell.2020.05.025. Epub 2020 May 18. PMID: 32425270; PMCID: PMC7231725.

11. Xiaoli W , Xianghua G , Qianqian X ,et al.Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients[J].Clinical Infectious Diseases, 2020.DOI:10.1093/cid/ciaa721.

12. Gao Y, Li Q, Shi H, Feng Y, Zhang T, Chen Y, Liang L, Chen D, Wu H, Jin R, Huang X. Preliminary Exploration of the Cause of Liver Disorders During Early Stages in COVID-19 Patients. Front Med (Lausanne). 2020 Aug 7;7:501. doi: 10.3389/fmed.2020.00501. PMID: 32903864; PMCID: PMC7443567.

13. Jiao Y, Xu P, Shi H, Chen D, Shi H. Advances on liver cell-derived exosomes in liver diseases. J Cell Mol Med. 2021 Jan;25(1):15-26. doi: 10.1111/jcmm.16123. Epub 2020 Nov 27. PMID: 33247543; PMCID: PMC7810930.

14. Hu ZJ, Xu J, Yin JM, Li L, Hou W, Zhang LL, Zhou Z, Yu YZ, Li HJ, Feng YM, Jin RH. Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients. Front Immunol. 2020 Sep 29;11:585647. doi: 10.3389/fimmu.2020.585647. PMID: 33133104; PMCID: PMC7550399.

15. Su B, Yin J, Lin X, Zhang T, Yao X, Xu Y, Lu Y, Wang W, Liu K, Zhang J, Xie L, Jin R, Feng Y. Quantification of SARS-CoV-2 antigen levels in the blood of patients with COVID-19. Sci China Life Sci. 2021 Jul;64(7):1193-1196. doi: 10.1007/s11427-020-1830-8. Epub 2020 Nov 26. PMID: 33259038; PMCID: PMC7706695.

16. Wu M, Liu Z, Li X, Zhang A, Li N. Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma. Onco Targets Ther. 2020 Jan 28;13:827-840. doi: 10.2147/OTT.S229835. PMID: 32095079; PMCID: PMC6995291.

17. Zhang X, Guo L, Zhang X, Xu L, Tian Y, Fan Z, Wei H, Zhang J, Ren F. GLT25D2 Is Critical for Inflammatory Immune Response to Promote Acetaminophen-Induced Hepatotoxicity by Autophagy Pathway. Front Pharmacol. 2020 Sep 18;11:01187. doi: 10.3389/fphar.2020.01187. PMID: 33071774; PMCID: PMC7530273.

18. Xu L, Zhang X, Tian Y, Fan Z, Li W, Liu M, Hu J, Duan Z, Jin R, Ren F. The critical role of PPARα in the binary switch between life and death induced by endoplasmic reticulum stress. Cell Death Dis. 2020 Aug 11;11(8):691. doi: 10.1038/s41419-020-02811-4. PMID: 32826849; PMCID: PMC7443130.

19. 劉曉霓,寇卜心,柴夢音,陳德喜.p53凋亡刺激蛋白2基因敲除小鼠的構(gòu)建及其對二乙基亞硝胺誘導(dǎo)肝癌的影響[J].中華肝臟病雜志,2020,28(09):784-789.

20. 魏飛力,吳夢麗,郭麗,等. 基于網(wǎng)絡(luò)藥理學(xué)探析瑞香狼毒活性成分治療晚期肝細胞癌的分子機制[J]. 世界科學(xué)技術(shù)-中醫(yī)藥現(xiàn)代化,2020,22(4):1004-1010. DOI:10.11842/wst.20190620003.

21. 李愛靜,林雪君,尹玲,等. 超聲造影觀察小鼠兩種皮下移植瘤的血管生成[J]. 實驗動物科學(xué),2020,37(4):27-32. DOI:10.3969/j.issn.1006-6179.2020.04.006.

22. 王陽,車陽,高玉雪,等. 自噬相關(guān)基因Atg7的表達對乙型肝炎病毒復(fù)制的影響[J]. 中國醫(yī)藥導(dǎo)報,2020,17(2):4-8.

23. 龐麗君,劉道潔,林明華,等. 血管內(nèi)皮生長因子原核表達載體的構(gòu)建及表達[J]. 中國醫(yī)藥導(dǎo)報,2020,17(23):4-7,封3.

24. 龐麗君, 石英, 郭向華,等. 穩(wěn)定表達HBx的人肝細胞系7702的建立[J]. 實用肝臟病雜志, 2020, v.23(03):22-25.

25. 關(guān)媛月,林明華,殷繼明,等. 整合素在腫瘤免疫過程中作用的研究進展[J]. 細胞與分子免疫學(xué)雜志,2020,36(8):750-754.

26. 焦彥,許萍,時紅波,等. ASPP2在肝臟疾病中的研究進展[J]. 肝臟,2020,25(5):553-555. DOI:10.3969/j.issn.1008-1704.2020.05.036.

27. 岳秀娟,王珊珊,石英,等.FOXA1基因表達CMV載體的構(gòu)建[J].北京醫(yī)學(xué),2020,42(06):571-572+577.DOI:10.15932/j.0253-9713.2020.06.024.

28. 張向穎,徐玲,田原,等. CHOP信號分子在PPARα激活抑制小鼠急性肝衰竭炎癥反應(yīng)中的作用研究[J]. 中華肝臟病雜志,2020,28(7):613-618. DOI:10.3760/cma.j.cn501113-20200608-00298.

29. 潘興富,歐陽雅博.淺談跨學(xué)科培養(yǎng)對醫(yī)學(xué)研究生綜合素質(zhì)提升的重要性[J].繼續(xù)醫(yī)學(xué)教育,2020,34(04):50-51.